✦ LIBER ✦

Systemic and splanchnic effects of acute administration of losartan — a specific angiotensin II receptor antagonist — in normal and portal hypertensive rats

✍ Scribed by V. Croquet; F. Oberti; F. Moal; J. Wang; J. Roux; N. Veal; P. Cales

Book ID: 119527047
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 158 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81092-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of losartan, a nonpeptide angiot

Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats

✍ Kenji Mizuno; Makio Tani; Shigeatsu Hashimoto; Susumu Niimura; Hironobu Sanada; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Acute effect of propranolol on splanchni

Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats

✍ Calès, Paul; Braillon, Alain; Girod, Catherine; Lebrec, Didier 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Haemodynamic effects of chronic administ

Haemodynamic effects of chronic administration of losartan, an angiotensin II receptor anatagonist, in patients with cirrhosis and portal hypertension

✍ D. Tripathi; G. Therapondos; H.F. Lui; D.J. Webb; P.C. Hayes 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Chronic hemodynamic and antifibrotic eff

Chronic hemodynamic and antifibrotic effects of a specific angiotensin II receptor antagonist (losartan) in bile duct ligated (BDL) rats and in portal vein ligated (PVL) rats

✍ V. Croquet; F. Moal; F. Oberti; J. Wang; J. Roux; N. Veal; E. Vuillemin; Y. Gall 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Effects of ritanserin, a selective and s

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats

✍ Frederik Nevens; M. Pilar Pizcueta; Mercedes Fernández; Dr. Jaime Bosch; Joan Ro 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Serotonergic mechanisms have recently been implicated in the pathogenesis of portal hypertension; this suggests that blockade of serotonin S2 receptors may be a new approach for the pharmacological therapy of portal hypertension. This study was aimed at investigating the effects of ritanserin, a sel

THE EFFECTS OF CENTRAL ADMINISTRATION OF

THE EFFECTS OF CENTRAL ADMINISTRATION OF ANGIOTENSIN II TYPE-1 RECEPTOR ANTAGONIST, CV-11974, IN NEPHRECTOMIZED SPONTANEOUSLY HYPERTENSIVE RATS

✍ Atsushi Kamitani; Koichi Higashimori; Katsuhiko Kohara; Jitsuo Higaki; Hiroshi M 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB